Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted panels, flux analysis, and lipidomics services. The company offers solutions for cancer metabolism; metabolic flux analysis; functional food; neurobiology research; renal and disease markers; skin and dermo-metabolomics; T-cell and B-cell metabolism; bacterial, fungal, and algae metabolism; tastant profiling; biomarker discovery, mitochondrial metabolism; patient profiling and subtyping; cellular engineering; and biomanufacturing and metabolomics applications. Human Metabolome Technologies, Inc. has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.
Research context
Human Metabolome Technologies, Inc appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Human Metabolome Technologies, Inc is currently in a long term downtrend where the price is trading 0.6% below its 200 day moving average.
From a valuation standpoint, the stock is 93.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.
Human Metabolome Technologies, Inc's total revenue rose by 13.8% to $292M since the same quarter in the previous year.
Its net income has increased by 198.7% to $30M since the same quarter in the previous year.
Based on the above factors, Human Metabolome Technologies, Inc gets an overall score of 3/5.